July 01, 2014
Valeant Pharmaceuticals International Inc. subsidiary Bausch & Lomb Inc. and Japanese drugmaker Senju Pharmaceutical Co. have recently sued India-based Lupin Ltd. in New Jersey federal court, seeking to block a generic version of Prolensa, an anti-inflammatory eye-drop medication.